LA MARCA, GIANCARLO
 Distribuzione geografica
Continente #
EU - Europa 17.767
NA - Nord America 15.062
AS - Asia 6.679
SA - Sud America 1.101
AF - Africa 160
OC - Oceania 112
Continente sconosciuto - Info sul continente non disponibili 3
Totale 40.884
Nazione #
US - Stati Uniti d'America 14.838
PL - Polonia 9.110
RU - Federazione Russa 2.991
IT - Italia 2.650
SG - Singapore 1.818
CN - Cina 1.458
HK - Hong Kong 918
BR - Brasile 872
VN - Vietnam 825
IE - Irlanda 710
SE - Svezia 595
KR - Corea 578
FI - Finlandia 397
FR - Francia 294
DE - Germania 292
IN - India 229
GB - Regno Unito 220
BD - Bangladesh 172
NL - Olanda 132
ID - Indonesia 130
CA - Canada 129
AU - Australia 112
JP - Giappone 108
TR - Turchia 101
AR - Argentina 93
CH - Svizzera 79
JO - Giordania 78
UA - Ucraina 78
IQ - Iraq 60
ES - Italia 55
MX - Messico 48
EC - Ecuador 42
DK - Danimarca 36
BE - Belgio 32
CI - Costa d'Avorio 32
ZA - Sudafrica 31
PK - Pakistan 26
CO - Colombia 24
NG - Nigeria 24
AT - Austria 22
CL - Cile 20
MA - Marocco 18
PH - Filippine 16
UZ - Uzbekistan 15
MY - Malesia 14
NP - Nepal 14
AE - Emirati Arabi Uniti 13
IR - Iran 13
PE - Perù 13
SA - Arabia Saudita 13
EG - Egitto 12
JM - Giamaica 11
TW - Taiwan 11
UY - Uruguay 11
VE - Venezuela 11
RO - Romania 10
KE - Kenya 9
PY - Paraguay 9
DZ - Algeria 8
GT - Guatemala 8
KZ - Kazakistan 8
LT - Lituania 8
IL - Israele 7
AL - Albania 6
AZ - Azerbaigian 6
KW - Kuwait 6
LB - Libano 6
RS - Serbia 6
SN - Senegal 6
TH - Thailandia 6
BG - Bulgaria 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
HN - Honduras 5
MM - Myanmar 5
HU - Ungheria 4
LV - Lettonia 4
MK - Macedonia 4
PA - Panama 4
TN - Tunisia 4
UG - Uganda 4
AM - Armenia 3
BS - Bahamas 3
BY - Bielorussia 3
CR - Costa Rica 3
GR - Grecia 3
MD - Moldavia 3
PS - Palestinian Territory 3
SC - Seychelles 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
BJ - Benin 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
Totale 40.853
Città #
Warsaw 9.094
Santa Clara 2.596
Ashburn 1.887
Fairfield 1.375
Singapore 1.367
Hong Kong 761
Dublin 694
Woodbridge 647
Seattle 591
Houston 582
Chandler 579
Cambridge 578
Seoul 531
Wilmington 488
Milan 426
San Jose 407
Beijing 312
Florence 295
Ann Arbor 280
Hefei 255
Lawrence 251
Altamura 248
Ho Chi Minh City 227
Rome 225
Los Angeles 224
Helsinki 204
Princeton 201
The Dalles 175
Council Bluffs 171
Lauterbourg 171
Hanoi 164
Buffalo 158
Dallas 154
Jacksonville 133
New York 131
Mumbai 121
Boston 120
Boardman 116
Moscow 115
Jakarta 110
Dong Ket 107
Medford 101
Melbourne 101
Naples 90
San Diego 88
Phoenix 86
Tokyo 85
São Paulo 76
Bern 68
Munich 62
Shanghai 61
Kent 56
Bologna 54
Paris 52
Izmir 51
London 51
Amsterdam 45
Turin 45
Clifton 41
Redondo Beach 41
Chicago 40
Frankfurt am Main 39
Orem 38
Porto Alegre 38
Lappeenranta 36
Falls Church 35
Toronto 35
Brooklyn 33
Norwalk 33
Abidjan 32
Atlanta 31
Bari 30
Haiphong 29
San Francisco 29
Da Nang 28
Genoa 28
Catania 27
Brussels 26
Figino 26
Guangzhou 26
Baghdad 25
Hillsboro 25
Copenhagen 24
Abuja 23
Seongnam 23
Rio de Janeiro 22
Turku 22
Belo Horizonte 21
Vienna 20
Andover 19
North York 19
Palermo 19
Bengaluru 18
Chennai 18
Shenzhen 18
Tianjin 18
Washington 18
Curitiba 17
Miano 17
Redwood City 17
Totale 29.567
Nome #
Enhanced interpretation of newborn screening results without analyte cutoff values. 620
Are patients with potential celiac disease really potential? The answer of metabonomics 408
Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates 400
Expanded newborn screening by mass spectrometry: New tests, future perspectives 393
Barth syndrome presenting with acute metabolic decompensation in the neonatal period. 384
Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap. 380
Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency 369
The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry 365
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency 358
A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry 344
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients 343
Genetic and biochemical approach to early prenatal diagnosis in a family with mut methylmalonic aciduria. 339
Detection of Honeybee Venom in Envenomed Tissues by Direct MALDI MSI 337
Safety and tolerability of antiepileptic drug treatment in children with epilepsy. 335
Insulin-resistant hyperglycaemia complicating neonatal onset of methylmalonic and propionic acidaemias. 334
Neonatal screening for severe combinedimmunodeficiency caused by an adenosine deaminase defect: a reliable andinexpensive method using tandem mass spectrometry. 332
Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots 331
Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress. 327
First prenatal molecular diagnosis in a family with holocarboxylase synthetase deficiency. 325
Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots 323
Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies. 321
Urine karatan sulfate (uKS) in Morquio syndrome type A patients measured via LC-MS/MS method: Improved KS detection as compared to dye-based methods and report of age-specific uKS reference ranges 321
Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study. 319
Metabolic newborn screening: Between past and future 317
Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment. 315
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 315
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP) 314
Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol 310
Estimating the integrity of aged DNA samples by CE 307
Simultaneous determination of creatine and guanidinoacetate in plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS). 304
Rapid determination of orotic acid in urine by a fast liquid chromatography/tandem mass spectrometric method. 303
Late-onset n-acetylglutamate synthase deficiency: Report of a paradigmatic adult case presenting with headaches and review of the literature 301
Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. 300
The Newborn Screening Program in Italy: Comparison with Europe and other Countries 300
Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease. 299
Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options 298
Falsely elevated C4-carnitine as expression of glutamate formiminotransferase deficiency in tandem mass spectrometry newborn screening. 298
Propranolol 0.2% eye micro-drops for retinopathy of prematurity: A prospective phase IIb study 297
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. 297
3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency: Identification of a New Mutation Causing Hyperinsulinemic Hypoketotic Hypoglycemia, Altered Organic Acids and Acylcarnitines Concentrations 293
Strategies for reducing the incidence of skin complications in newborns treated with whole-body hypothermia. 293
Study protocol: Safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): A multicenter, open-label, single arm, phase II trial 290
The successful inclusion of succinylacetone as a marker of Tyrosinemia Type I in Tuscany newborn screening program. 286
Children who develop type 1 diabetes early in life show low levels of carnitine and amino acids at birth: does this finding shed light on the etiopathogenesis of the disease? 286
Newborn screening for homocystinurias: recent recommendations versus current practice 285
The italian XLMR bank: a clinical and molecular database 281
Rapid diagnosis of medium chain Acyl Co-A dehydrogenase (MCAD) deficiency in a newborn by liquid chromatography/tandem mass spectrometry. 278
Analysis of organic acids and acylglycines for the diagnosis of related inborn errors of metabolism by GC- and HPLC-MS. 278
Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot. 278
LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization 278
Hyperhydroxyprolinaemia: a new case diagnosed during neonatal screening with tandem mass spectrometry. 277
Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia 276
New developments in the treatment of hyperammonemia: emerging use of carglumic acid. 273
Reducing the False-Positive Rate for Isovalerylcarnitine in Expanded Newborn Screening: The Application of a Second-Tier Test 270
Hypothermia for neonatal hypoxic-ischemic encephalopathy: may an early amplitude-integrated EEG improve the selection of candidates for cooling? 269
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI). 269
Orange-colored diapers as first sign of Lesch-Nyhan disease in an asymptomatic infant. 265
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 262
Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies 261
Study on stability of a chloral hydrate solution used as sedative in a paediatric hospital by tandem mass spectromerty 260
Fatal Malonyl CoA Decarboxylase Deficiency Due to Maternal Uniparental Isodisomy of the Telomeric End of Chromosome 16 254
Haematohidrosis treated with propranolol: A case report 252
Data in support for the measurement of heparan sulfate and dermatan sulfate by LC–MS/MS analysis 251
Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. 250
Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias 250
Topiramate Concentrations In Neonates Treated With Prolonged Whole Body Hypothermia For Hypoxic Ischaemic Encephalopathy 249
Mass spectrometry in clinical chemistry: the case of newborn screening 248
Arginine in older patients with persistent atrial fibrillation: A link to endothelial dysfunction? 243
Delayed-onset adenosine deaminase deficiency: Strategies for an early diagnosis. 243
Serum amino acid profiles in normal subjects and in patients with or at risk of Alzheimer dementia 241
Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry 238
Reference intervals for orotic acid in urine, plasma and dried blood spot using hydrophilic interaction liquid chromatography-tandem mass spectrometry. 237
First-in-human phase I/II clinical trial of hematopoietic stem and progenitor cell gene therapy for Hurler syndrome: Favorable safety profile and extensive metabolic correction 232
Screening neonatale per malattie metaboliche ereditarie mediante spettrometria di massa 231
Development of a fast LC-MS/MS protocol for combined measurement of six LSDs on dried blood spot in a newborn screening program 229
Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry. 227
The 'headache tree' via umbellulone and TRPA1 activates the trigeminovascular system 225
Newborn Screening: Are We Ready for It? 225
A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain 220
Pre and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS 216
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 206
Proteinuria impairs podocyte regeneration by sequestering retinoic acid. 204
β3-adrenoceptor as a potential immuno-suppressor agent in melanoma 204
The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. 201
A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy. 198
Effect of Beta 3 Adrenoreceptor Modulation on Patency of the Ductus Arteriosus 194
High frequency of biotinidase deficiency in Italian population identified by newborn screening 194
Biotinidase deficiency due to a de novo mutation or gonadal mosaicism in a first child. 193
Phenotypic and genetic spectrum of ATP6V1A encephalopathy: a disorder of lysosomal homeostasis 191
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 190
Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry 188
Serum creatinine during physiological perinatal dehydration may estimate individual nephron endowment 187
Ex vivo hematopoietic stem cell gene therapy for mucopolysaccharidosis type I (Hurler syndrome) 186
ONDANSETRON PRE-TREATMENT FACILITATES BLOOD-BRAIN BARRIER PENETRATION OF DOXORUBICIN IN RAT MODEL 186
Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice 186
MS-IMAGING: IN SITU INVESTIGATION OF SECONDARY METABOLITES OF ORYZA SATIVA L. VARIETIES BEFORE AND AFTER COOKING 185
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study 185
The successful inclusion of ADA SCID in Tuscany expanded newborn screening program 183
Aminoacylase I deficiency due to ACY1 mRNA exon skipping. 182
Liver-Directed Adeno-Associated Virus–Mediated Gene Therapy for Mucopolysaccharidosis Type VI 180
Totale 27.575
Categoria #
all - tutte 104.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021292 0 0 0 0 0 0 0 0 0 0 0 292
2021/20221.356 35 140 128 35 48 99 85 93 44 109 188 352
2022/20233.314 309 621 173 185 211 566 424 188 330 47 110 150
2023/20241.459 90 154 219 74 119 151 95 293 43 92 59 70
2024/20258.308 306 938 557 1.277 2.388 964 174 363 411 235 309 386
2025/202611.520 961 1.306 881 992 1.040 545 1.310 700 821 733 768 1.463
Totale 41.210